Please assess the completion status of the following clinical trial:

Trial Title: Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients between 18 and 55 years old at screening~* Documented HIV-1 infection~* Currently HAART-treated~* Plasma HIV-RNA below 50 copies/ml at screening~* Lymphocyte T CD4+ count above or equal to 100/mm3 at the NHL diagnosis~* Histologically proven large cell NHL in first remission with classical poor prognostic factors (IPI above or equal to 2) or in second remission whatever IPI.~* Biological criteria of eligibility for intensive therapeutic~* Signed written informed consent~* Patient protected by the social security of one of the European community countries.~Exclusion Criteria:~* Burkitt NHL~* Central nervous system NHL~* Patients already treated by ASCT~* Ongoing infectious disease~* Psychiatric disease~* Left ventricular ejection fraction \< 25%~* Creatinine clearance \< 50 ml/min~* Hepatic failure~* Uncontrolled high blood pressure~* Chronic hepatitis C or B~* Participating in other trials.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).